Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

New frontiers in gene therapy: treatment of erectile dysfunction

April 20, 1999

(+)-SNAP-6991 discovered at Synaptic and Merck as orally active, uroselective alpha1a blocker

April 5, 1999

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

April 1, 1999

Pharmacokinetics and pharmacodynamics of VPA-985 in healthy volunteers

March 31, 1999

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

March 30, 1999

U.S. patent issues to Vivus for second-generation ED therapeutic

March 29, 1999

Asahi Chemical launches alpha-adrenoceptor antagonist in Japan

March 26, 1999

Potassium and/or chloride channel modulators claimed for incontinence and IBS

March 25, 1999

Dainippon's AH-9700 is an excellent candidate for treatment of urge incontinence

March 25, 1999

Recordati presents new series for lower urinary tract dysfunction

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...